What is the recommended supportive treatment for melasma?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Supportive Treatment for Melasma

The most effective supportive treatment for melasma includes strict sun protection with broad-spectrum SPF 70 or higher sunscreen, combined with topical agents such as hydroquinone 4% or triple combination cream (hydroquinone 4%, tretinoin 0.05%, and fluocinolone acetonide 0.01%). 1, 2, 3

First-Line Treatments

Sun Protection

  • Mandatory use of broad-spectrum sunscreen (SPF 70+) daily
  • Protective clothing when outdoors
  • Sun avoidance, especially during peak hours
  • Note: Inadequate sun protection is the most common reason for treatment failure 1

Topical Treatments

  1. Hydroquinone 4% cream

    • FDA-approved for gradual bleaching of hyperpigmented skin conditions including melasma 2
    • Apply once or twice daily for 8-12 weeks
    • Requires skin sensitivity testing before use
    • Should not be used continuously beyond 6 months due to risk of ochronosis 1
  2. Triple combination cream (preferred option)

    • Contains 4% hydroquinone, 0.05% tretinoin, and 0.01% fluocinolone acetonide
    • 77-94% of patients achieve clear or almost clear skin 3
    • Apply once daily in the evening
    • More effective than monotherapy 4

Second-Line and Adjunctive Treatments

Alternative Topical Agents

  • Niacinamide 4% - Showed good to excellent improvement in 44% of patients compared to 55% with hydroquinone, with fewer side effects (18% vs 29%) 5
  • Azelaic acid (15-20%) - Less irritating alternative with similar efficacy to hydroquinone 1
  • Kojic acid - Natural alternative with fewer side effects 1
  • Tranexamic acid - Promising topical agent for resistant cases 1, 6

Oral Therapy

  • Tranexamic acid (250 mg twice daily)
    • For moderate to severe cases resistant to topical therapy
    • Requires monitoring for thromboembolic risk
    • Emerging as an effective systemic treatment 1, 4

Procedural Interventions

  • Chemical peels

    • Consider after 8-12 weeks of unsuccessful topical therapy
    • Typically 3-4 sessions spaced one month apart
    • Glycolic acid or salicylic acid peels are commonly used 1
  • Platelet-Rich Plasma (PRP) therapy

    • Recent evidence shows PRP intradermal injections are effective for melasma
    • Can be used alone or in combination with tranexamic acid
    • Significantly better results seen with intradermal PRP than intradermal tranexamic acid 7
    • Treatment protocol: once a month for three to five sessions

Monitoring and Follow-up

  • Evaluate response every 4-6 weeks using standardized photography
  • Use Melasma Area and Severity Index (MASI) score to assess improvement
  • Adjust treatment if no improvement after 8-12 weeks 1
  • Continue strict sun protection indefinitely, even after clearing

Common Pitfalls and Caveats

  1. Neglecting sun protection - Even minimal sun exposure can sustain melanocytic activity and reverse treatment benefits 1, 2

  2. Prolonged hydroquinone use - Can lead to ochronosis (blue-black discoloration) with use beyond 6 months 1

  3. Ignoring hormonal factors - Oral contraceptives or hormone replacement therapy can impact treatment outcomes 1

  4. Discontinuing treatment too early - Melasma is chronic and requires long-term management to prevent recurrence 6

  5. Aggressive treatments - High-concentration peels or laser treatments can worsen hyperpigmentation, especially in darker skin types 1

  6. Unrealistic expectations - Patients should understand that melasma treatment is long-term and complete resolution may not be possible 6

  7. Hydroquinone safety concerns - Some studies have demonstrated carcinogenic potential in animals, though human risk remains unknown 2

References

Guideline

Postinflammatory Hypopigmentation and Hyperpigmentation Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Melasma Treatment: An Evidence-Based Review.

American journal of clinical dermatology, 2020

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.